Treatment with 2 commercial antibiotics reduced clinical and systemic signs of pneumonia and the abundance of pathogenic bacteria in the upper respiratory tract of preweaning dairy calves

ABSTRACT: The aim of this study was to evaluate the effect of therapeutically administered tildipirosin or florfenicol + flunixin meglumine for the treatment of bovine respiratory disease (BRD) accompanied by fever in calves before weaning compared with diseased and untreated animals. As specific ob...

Full description

Bibliographic Details
Main Authors: A.C.C.H. Tomazi, T. Tomazi, L. Bringhenti, A.P.A. Vinhal, M.X. Rodrigues, T.R. Bilby, H.J. Huson, R.C. Bicalho
Format: Article
Language:English
Published: Elsevier 2023-04-01
Series:Journal of Dairy Science
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0022030223000504
_version_ 1797854601310896128
author A.C.C.H. Tomazi
T. Tomazi
L. Bringhenti
A.P.A. Vinhal
M.X. Rodrigues
T.R. Bilby
H.J. Huson
R.C. Bicalho
author_facet A.C.C.H. Tomazi
T. Tomazi
L. Bringhenti
A.P.A. Vinhal
M.X. Rodrigues
T.R. Bilby
H.J. Huson
R.C. Bicalho
author_sort A.C.C.H. Tomazi
collection DOAJ
description ABSTRACT: The aim of this study was to evaluate the effect of therapeutically administered tildipirosin or florfenicol + flunixin meglumine for the treatment of bovine respiratory disease (BRD) accompanied by fever in calves before weaning compared with diseased and untreated animals. As specific objectives, we evaluated the composition of the bacterial microbiota of the upper respiratory tract (URT) and blood and health parameters of the animals. Preweaning Holstein female calves diagnosed with naturally acquired pneumonia were randomly assigned to one of the following experimental groups on the day of diagnosis (d 0): (1) TLD (n = 36): single subcutaneous injection with 4 mg/kg tildipirosin; (2) FLF (n = 33): single subcutaneous injection with an antimicrobial (40 mg/kg florfenicol) combined with a nonsteroidal anti-inflammatory drug (2.2 mg/kg flunixin meglumine); and (3) NEG (n = 35): no treatment within the first 5 d following enrollment. The NEG treatment group was closely monitored for 5 d, and calves were removed from the study following a standardized late treatment protocol, when necessary, to minimize health concerns. Healthy untreated calves (CTR; n = 31) were also selected for the study and used as controls. Blood samples used for biochemical analysis and nasopharyngeal swabs used for evaluation of URT microbiota were collected daily from d 0 until d 5 and then weekly until weaning. Next-generation sequencing of the 16S rRNA gene was used to assess the URT microbiota at the phylum and genus levels. Clinical signs associated with pneumonia and otitis media were assessed daily, as was the need for antibiotic interventions. Calves in the TLD and FLF groups had faster recovery from fever within the first 5 d after enrollment. In addition, antibiotic-treated calves reached the same serum haptoglobin levels as healthy calves on d 2 after diagnosis, whereas calves in the NEG group had higher haptoglobin levels than the CTR group until at least d 5 after BRD diagnosis. Calves in the TLD and FLF groups had a lower risk of treatment for pneumonia (FLF = 22.8%; TLD = 27.7%) from d 5 to weaning than calves in the NEG group (54.7%). Furthermore, FLF treatment had a significantly lower risk of nasal discharge, otitis media, and treatment failure compared with the NEG group, but did not differ from the TLD group. Differences in the composition of the URT microbiota were found between groups, and the genus Mycoplasma was the most abundant in samples collected from the URT of calves with and without pneumonia. Both drugs were effective in reducing the mean relative abundance (MRA) of important genera associated with pneumonia (Mannheimia and Pasteurella), although an increase in Mycoplasma MRA was observed for tildipirosin-treated calves. In conclusion, both drugs were effective in reducing the inflammatory signs of pneumonia and the need for antimicrobial treatment after enrollment compared with no treatment. In addition, both TLD and FLF were effective in reducing the MRA of important bacterial genera associated with pneumonia; however, TLD treatment was associated with increased Mycoplasma MRA compared with healthy and untreated calves.
first_indexed 2024-04-09T20:09:50Z
format Article
id doaj.art-746e6e0a2c7e433da48b53e5b2c262cf
institution Directory Open Access Journal
issn 0022-0302
language English
last_indexed 2024-04-09T20:09:50Z
publishDate 2023-04-01
publisher Elsevier
record_format Article
series Journal of Dairy Science
spelling doaj.art-746e6e0a2c7e433da48b53e5b2c262cf2023-04-01T08:40:53ZengElsevierJournal of Dairy Science0022-03022023-04-01106427502771Treatment with 2 commercial antibiotics reduced clinical and systemic signs of pneumonia and the abundance of pathogenic bacteria in the upper respiratory tract of preweaning dairy calvesA.C.C.H. Tomazi0T. Tomazi1L. Bringhenti2A.P.A. Vinhal3M.X. Rodrigues4T.R. Bilby5H.J. Huson6R.C. Bicalho7Department of Population Medicine and Diagnostic Sciences, Cornell University, Ithaca, NY 14853Department of Population Medicine and Diagnostic Sciences, Cornell University, Ithaca, NY 14853; Merck Animal Health, Madison, NJ 07940; Corresponding authorDepartment of Population Medicine and Diagnostic Sciences, Cornell University, Ithaca, NY 14853; FERA Animal Health LLC, College Station, TX 77845Department of Population Medicine and Diagnostic Sciences, Cornell University, Ithaca, NY 14853Department of Population Medicine and Diagnostic Sciences, Cornell University, Ithaca, NY 14853; FERA Animal Health LLC, College Station, TX 77845Merck Animal Health, Madison, NJ 07940Department of Animal Sciences, Cornell University, Ithaca, NY 14853Department of Population Medicine and Diagnostic Sciences, Cornell University, Ithaca, NY 14853; FERA Animal Health LLC, College Station, TX 77845ABSTRACT: The aim of this study was to evaluate the effect of therapeutically administered tildipirosin or florfenicol + flunixin meglumine for the treatment of bovine respiratory disease (BRD) accompanied by fever in calves before weaning compared with diseased and untreated animals. As specific objectives, we evaluated the composition of the bacterial microbiota of the upper respiratory tract (URT) and blood and health parameters of the animals. Preweaning Holstein female calves diagnosed with naturally acquired pneumonia were randomly assigned to one of the following experimental groups on the day of diagnosis (d 0): (1) TLD (n = 36): single subcutaneous injection with 4 mg/kg tildipirosin; (2) FLF (n = 33): single subcutaneous injection with an antimicrobial (40 mg/kg florfenicol) combined with a nonsteroidal anti-inflammatory drug (2.2 mg/kg flunixin meglumine); and (3) NEG (n = 35): no treatment within the first 5 d following enrollment. The NEG treatment group was closely monitored for 5 d, and calves were removed from the study following a standardized late treatment protocol, when necessary, to minimize health concerns. Healthy untreated calves (CTR; n = 31) were also selected for the study and used as controls. Blood samples used for biochemical analysis and nasopharyngeal swabs used for evaluation of URT microbiota were collected daily from d 0 until d 5 and then weekly until weaning. Next-generation sequencing of the 16S rRNA gene was used to assess the URT microbiota at the phylum and genus levels. Clinical signs associated with pneumonia and otitis media were assessed daily, as was the need for antibiotic interventions. Calves in the TLD and FLF groups had faster recovery from fever within the first 5 d after enrollment. In addition, antibiotic-treated calves reached the same serum haptoglobin levels as healthy calves on d 2 after diagnosis, whereas calves in the NEG group had higher haptoglobin levels than the CTR group until at least d 5 after BRD diagnosis. Calves in the TLD and FLF groups had a lower risk of treatment for pneumonia (FLF = 22.8%; TLD = 27.7%) from d 5 to weaning than calves in the NEG group (54.7%). Furthermore, FLF treatment had a significantly lower risk of nasal discharge, otitis media, and treatment failure compared with the NEG group, but did not differ from the TLD group. Differences in the composition of the URT microbiota were found between groups, and the genus Mycoplasma was the most abundant in samples collected from the URT of calves with and without pneumonia. Both drugs were effective in reducing the mean relative abundance (MRA) of important genera associated with pneumonia (Mannheimia and Pasteurella), although an increase in Mycoplasma MRA was observed for tildipirosin-treated calves. In conclusion, both drugs were effective in reducing the inflammatory signs of pneumonia and the need for antimicrobial treatment after enrollment compared with no treatment. In addition, both TLD and FLF were effective in reducing the MRA of important bacterial genera associated with pneumonia; however, TLD treatment was associated with increased Mycoplasma MRA compared with healthy and untreated calves.http://www.sciencedirect.com/science/article/pii/S0022030223000504bovine respiratory disease (BRD)pneumonia treatmentrespiratory tract microbiotatildipirosinflorfenicol + flunixin meglumine
spellingShingle A.C.C.H. Tomazi
T. Tomazi
L. Bringhenti
A.P.A. Vinhal
M.X. Rodrigues
T.R. Bilby
H.J. Huson
R.C. Bicalho
Treatment with 2 commercial antibiotics reduced clinical and systemic signs of pneumonia and the abundance of pathogenic bacteria in the upper respiratory tract of preweaning dairy calves
Journal of Dairy Science
bovine respiratory disease (BRD)
pneumonia treatment
respiratory tract microbiota
tildipirosin
florfenicol + flunixin meglumine
title Treatment with 2 commercial antibiotics reduced clinical and systemic signs of pneumonia and the abundance of pathogenic bacteria in the upper respiratory tract of preweaning dairy calves
title_full Treatment with 2 commercial antibiotics reduced clinical and systemic signs of pneumonia and the abundance of pathogenic bacteria in the upper respiratory tract of preweaning dairy calves
title_fullStr Treatment with 2 commercial antibiotics reduced clinical and systemic signs of pneumonia and the abundance of pathogenic bacteria in the upper respiratory tract of preweaning dairy calves
title_full_unstemmed Treatment with 2 commercial antibiotics reduced clinical and systemic signs of pneumonia and the abundance of pathogenic bacteria in the upper respiratory tract of preweaning dairy calves
title_short Treatment with 2 commercial antibiotics reduced clinical and systemic signs of pneumonia and the abundance of pathogenic bacteria in the upper respiratory tract of preweaning dairy calves
title_sort treatment with 2 commercial antibiotics reduced clinical and systemic signs of pneumonia and the abundance of pathogenic bacteria in the upper respiratory tract of preweaning dairy calves
topic bovine respiratory disease (BRD)
pneumonia treatment
respiratory tract microbiota
tildipirosin
florfenicol + flunixin meglumine
url http://www.sciencedirect.com/science/article/pii/S0022030223000504
work_keys_str_mv AT acchtomazi treatmentwith2commercialantibioticsreducedclinicalandsystemicsignsofpneumoniaandtheabundanceofpathogenicbacteriaintheupperrespiratorytractofpreweaningdairycalves
AT ttomazi treatmentwith2commercialantibioticsreducedclinicalandsystemicsignsofpneumoniaandtheabundanceofpathogenicbacteriaintheupperrespiratorytractofpreweaningdairycalves
AT lbringhenti treatmentwith2commercialantibioticsreducedclinicalandsystemicsignsofpneumoniaandtheabundanceofpathogenicbacteriaintheupperrespiratorytractofpreweaningdairycalves
AT apavinhal treatmentwith2commercialantibioticsreducedclinicalandsystemicsignsofpneumoniaandtheabundanceofpathogenicbacteriaintheupperrespiratorytractofpreweaningdairycalves
AT mxrodrigues treatmentwith2commercialantibioticsreducedclinicalandsystemicsignsofpneumoniaandtheabundanceofpathogenicbacteriaintheupperrespiratorytractofpreweaningdairycalves
AT trbilby treatmentwith2commercialantibioticsreducedclinicalandsystemicsignsofpneumoniaandtheabundanceofpathogenicbacteriaintheupperrespiratorytractofpreweaningdairycalves
AT hjhuson treatmentwith2commercialantibioticsreducedclinicalandsystemicsignsofpneumoniaandtheabundanceofpathogenicbacteriaintheupperrespiratorytractofpreweaningdairycalves
AT rcbicalho treatmentwith2commercialantibioticsreducedclinicalandsystemicsignsofpneumoniaandtheabundanceofpathogenicbacteriaintheupperrespiratorytractofpreweaningdairycalves